() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: General Cannabis Corp

Leading Investment Newsletter Ranks GreenGro Technologies as 10th Most Attractive Stock to Own Out of List of 30 Other Cannabis Securities

Cannabidiol, or CBD, is a component of the marijuana plant. Unlike THC, CBD cannot give you a sense of euphoria or make you intoxicated.  What it can do, however, is provide anti-inflammatory, analgesic, anti-nausea and anti-seizure effects, according to industry experts.  While THC acts on certain cannabinoid receptors found in the brain and central nervous system, CBD works throughout the body.  GreenGro’s strategy all along was to allow the heavyweights, such as GW Pharmaceuticals and Insys Therapeutics, Inc. to spend the millions of research and development dollars it did not have to create the market for smaller yet more agile players such as GreenGro Technologies.  The Company expects to update investors on its latest developments in this arena very shortly.
Read more

General Cannabis Welcomes Top Denver Attorney, Brett Wendt, as Executive Vice President and General Counsel

The role of General Counsel is new to the Company and will support General Cannabis’ growth, as well as our focus on ensuring the most stringent compliance with regulatory agencies. However, as General Cannabis continues to target larger acquisitions and state-by-state expansion, the role of General Counsel and Wendt’s role as in-house strategic advisor will become critical to our comprehensive business strategy.
Read more